#neuroendocrine-tumors
Latest news and interesting information about neuroendocrine-tumors.
Cabometyx Cuts Neuroendocrine Tumor Risk
Exelixis announces Cabometyx reduces neuroendocrine tumor progression risk by 74% in CABINET trial. New data presented at ASCO.
...
